Estela Sánchez‐Herrero

Statistics

Publications

Citations

723

H-Index

Active since

2018

Affiliations

Hospital Universitario Puerta de Hierro Majadahonda(Current)

Institut Català d'Oncologia

University Hospital Complex Of Vigo

Complexo Hospitalario Universitario A Coruña

Hospital Universitario Fundación Jiménez Díaz

Estela Sánchez‐Herrero is an author at Hospital Universitario Puerta de Hierro Majadahonda specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2018–2022

Publications

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

Mariano Provencio, Roberto Serna‐Blasco, Ernest Nadal et al. · Journal of Clinical Oncology · 2022 · 335 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Laura Fachal, Hugues Aschard, Jonathan Beesley et al. · Nature Genetics · 2020 · 189 citations · Full text

Medicine, Genetics, Molecular Genetics +12

Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation

Miguel Barquín, Virginia Calvo, Francisco Garcia‐García et al. · Cancer Epidemiology · 2020 · 26 citations

Medicine, Oncology, Survival Analysis +9

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment

Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Vadym Ivanchuk et al. · Molecular Oncology · 2021 · 26 citations · Full text

Medicine, Molecular Medicine, Oncology +17

ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib

Atocha Romero, Roberto Serna‐Blasco, Estela Sánchez‐Herrero et al. · Translational Lung Cancer Research · 2020 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 14